Microbot Medical, Inc.

$MBOT is up over 100% and leading the Prism MarketView MedDevices index after they received FDA approval for a clinical trial for its LIBERTY® Endovascular Robotic Surgical System

Share This Article

 

About the Author

Microbot Medical, Inc.

Joey Ramson